Orders for Merck & Co's oral antiviral for COVID-19 helped to swell ... but even without the drug sales would have risen 19% thanks to a strong performance from cancer immunotherapy Keytruda ...
A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
Understanding the investment thesis for Merck requires appreciating the importance of its blockbuster cancer drug, Keytruda, ...
Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...